External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ICNMD 2022
Roche and Genentech at

ICNMD 2022

July 05 - July 09
Brussels, Belgium/ Virtual (Hybrid)
icnmd.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:15 PM
Duration 15mins Meeting Studio 211 + 212
Phase 1/2a trial of delandistrogene moxeparvovec in patients with DMD: 4-year update
Jerry R. Mendell, Zarife Sahenk, Kelly J. Lehman, Carrie Nease, Linda P. Lowes, Natalie F. Reash, Megan A. Iammarino, Lindsay N. Alfano, Jordan Vaiea, Sarah Lewis, Kathleen Church, Richard Shell, Rachael A. Potter, Danielle A. Griffin, Eric R. Pozsgai, Mark Hogan, Larry Hu, Kathryn Giblin, Louise R. Rodino-Klapac
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:15 PM
Duration 15mins Copper Hall
SUNFISH: 3-year efficacy and safety of risdiplam▼ in Types 2 and 3 spinal muscular atrophy
Nicolas Deconinck, John W Day, Elena S Mazzone, Andres Nascimento, Maryam Oskoui, Kayoko Saito, ​Carole Vuillerot, Giovanni Baranello, Odile Boespflug-Tanguy, Nathalie Goemans, Janbernd Kirschner, Anna Kostera-Pruszczyk, Laurent Servais, Jessica Braid, Marianne Gerber, Ksenija Gorni, Carmen Martin, Renata S Scalco, Wai Yin Yeung, Eugenio Mercuri, on behalf of the SUNFISH Working Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:00 PM
Duration 15mins Copper Hall
RAINBOWFISH: Preliminary efficacy and safety data in risdiplam▼-treated infants with presymptomatic SMA​
Richard S Finkel, Michelle A Farrar, Dmitry Vlodavets, Edmar Zanoteli, Mohammad Al-Muhaizea, Leslie Nelson, Alexandra Prufer, Laurent Servais, Yi Wang, Carolyn Fisher, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Laura Palfreeman, Renata S Scalco, Enrico Bertini, on behalf of the RAINBOWFISH Study Group​
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:15 PM
Duration 15mins Copper Hall
Risdiplam▼: pharmacokinetic, pharmacodynamic, safety and efficacy exposure response analyses ​
Heidemarie Kletzl, Yumi Cleary, Paul Grimsey, Marianne Gerber, Renata S Scalco
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:30 PM
Duration 15mins Copper Hall
Matching-adjusted Indirect Comparison of Risdiplam▼ Versus Nusinersen in Type 1 Spinal Muscular Atrophy: 2-year Update​
Neil Hawkins, Valerie Aponte Ribero, Ksenija Gorni, Monica Daigl, Yasmina Martí, Rachel Evans, David Alexander Scott, Anadi Mahajan ​
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.